JP2007509949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509949A5 JP2007509949A5 JP2006538191A JP2006538191A JP2007509949A5 JP 2007509949 A5 JP2007509949 A5 JP 2007509949A5 JP 2006538191 A JP2006538191 A JP 2006538191A JP 2006538191 A JP2006538191 A JP 2006538191A JP 2007509949 A5 JP2007509949 A5 JP 2007509949A5
- Authority
- JP
- Japan
- Prior art keywords
- proton
- pharmacologically active
- active ingredient
- composition
- accepting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002831 pharmacologic agent Substances 0.000 claims 31
- 239000000203 mixture Substances 0.000 claims 30
- 229960000223 tilmicosin Drugs 0.000 claims 12
- JTSDBFGMPLKDCD-XVFHVFLVSA-N tilmicosin Chemical compound O([C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CCN1C[C@H](C)C[C@H](C)C1)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O JTSDBFGMPLKDCD-XVFHVFLVSA-N 0.000 claims 12
- NOOCSNJCXJYGPE-UHFFFAOYSA-N flunixin Chemical compound C1=CC=C(C(F)(F)F)C(C)=C1NC1=NC=CC=C1C(O)=O NOOCSNJCXJYGPE-UHFFFAOYSA-N 0.000 claims 9
- 229960000588 flunixin Drugs 0.000 claims 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 6
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 claims 4
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 claims 4
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 4
- 239000004100 Oxytetracycline Substances 0.000 claims 4
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 claims 4
- 229960004099 azithromycin Drugs 0.000 claims 4
- 229960003184 carprofen Drugs 0.000 claims 4
- IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 claims 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims 4
- 229960003722 doxycycline Drugs 0.000 claims 4
- 229930195729 fatty acid Natural products 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 4
- 239000007972 injectable composition Substances 0.000 claims 4
- 229960002009 naproxen Drugs 0.000 claims 4
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 4
- 229960000625 oxytetracycline Drugs 0.000 claims 4
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims 4
- 235000019366 oxytetracycline Nutrition 0.000 claims 4
- 229960005224 roxithromycin Drugs 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 3
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 claims 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims 2
- 239000005639 Lauric acid Substances 0.000 claims 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims 2
- 229940111134 coxibs Drugs 0.000 claims 2
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 229940074076 glycerol formal Drugs 0.000 claims 2
- 150000002634 lipophilic molecules Chemical class 0.000 claims 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- 239000005642 Oleic acid Substances 0.000 claims 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 239000004098 Tetracycline Substances 0.000 claims 1
- 229940126575 aminoglycoside Drugs 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 230000002924 anti-infective effect Effects 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 229960000590 celecoxib Drugs 0.000 claims 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 1
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 1
- 229940041033 macrolides Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 235000019364 tetracycline Nutrition 0.000 claims 1
- 150000003522 tetracyclines Chemical class 0.000 claims 1
- 229940040944 tetracyclines Drugs 0.000 claims 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 150000003952 β-lactams Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51596703P | 2003-10-29 | 2003-10-29 | |
| PCT/US2004/035540 WO2005044254A1 (en) | 2003-10-29 | 2004-10-28 | Salts of pharmacologically active compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007509949A JP2007509949A (ja) | 2007-04-19 |
| JP2007509949A5 true JP2007509949A5 (enExample) | 2007-11-08 |
Family
ID=34572865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538191A Withdrawn JP2007509949A (ja) | 2003-10-29 | 2004-10-28 | 薬理学的に活性な化合物の塩 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050148519A1 (enExample) |
| EP (1) | EP1677781A4 (enExample) |
| JP (1) | JP2007509949A (enExample) |
| AU (1) | AU2004287439A1 (enExample) |
| CA (1) | CA2542509A1 (enExample) |
| WO (1) | WO2005044254A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0700969A (pt) * | 2007-03-22 | 2008-11-04 | Ouro Fino Participacoes E Empr | composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia |
| NZ588686A (en) | 2011-01-20 | 2013-07-26 | Bayer New Zealand Ltd | Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland |
| WO2013049749A2 (en) | 2011-09-29 | 2013-04-04 | Plx Pharma Inc. | pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME |
| JP6777734B2 (ja) * | 2015-06-10 | 2020-10-28 | ピードモント アニマル ヘルス インコーポレイテッド | 注射可能な抗生物質製剤及びその使用 |
| RU2666607C1 (ru) * | 2017-05-03 | 2018-09-11 | Общество С Ограниченной Ответственностью "Вик - Здоровье Животных" | Способ повышения стабильности инъекционной фармацевтической композиции |
| KR20220158031A (ko) | 2020-03-26 | 2022-11-29 | 피엘엑스 옵코 인코포레이티드 | pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| ATE318580T1 (de) * | 1996-12-20 | 2006-03-15 | Alza Corp | Gelzusammensetzungen und verfahren |
| DE69707927T2 (de) * | 1997-05-06 | 2002-04-11 | Norbrook Lab Ltd | Verbesserungen bezüglich langwirksamer antibiotika |
| US6677321B1 (en) * | 1999-12-09 | 2004-01-13 | Bruce Levin | Methods and compositions for treatment of inflammatory disease |
| US6726918B1 (en) * | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
| US20040033938A1 (en) * | 2000-09-12 | 2004-02-19 | Britten Nancy J. | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| US20030219461A1 (en) * | 2000-09-12 | 2003-11-27 | Britten Nancy J. | Parenteral combination therapy for infective conditions |
| US6787568B1 (en) * | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
| US6946137B2 (en) * | 2001-10-19 | 2005-09-20 | Idexx Laboratories, Inc. | Methods for the controlled delivery of pharmacologically active compounds |
| US6790867B2 (en) * | 2002-05-20 | 2004-09-14 | Schering-Plough Animal Health Corporation | Compositions and method for treating infection in cattle and swine |
| WO2003099293A1 (en) * | 2002-05-23 | 2003-12-04 | Danmarks Farmaceutiske Universitet | Pharmacologically active salts |
| DE10227938B4 (de) * | 2002-06-21 | 2006-07-20 | Heraeus Kulzer Gmbh | Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung |
| WO2005032523A1 (en) * | 2003-09-30 | 2005-04-14 | Acusphere, Inc. | Injectable, oral, or topical sustained release pharmaceutical formulations |
-
2004
- 2004-10-28 CA CA002542509A patent/CA2542509A1/en not_active Abandoned
- 2004-10-28 EP EP04818293A patent/EP1677781A4/en not_active Withdrawn
- 2004-10-28 JP JP2006538191A patent/JP2007509949A/ja not_active Withdrawn
- 2004-10-28 AU AU2004287439A patent/AU2004287439A1/en not_active Abandoned
- 2004-10-28 US US10/974,833 patent/US20050148519A1/en not_active Abandoned
- 2004-10-28 WO PCT/US2004/035540 patent/WO2005044254A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2492537T3 (es) | Composiciones que comprenden florfenicol o un compuesto relacionado estructuralmente para tratar infección en ganado bovino y porcino | |
| Lees | Analgesic, anti-inflammatory, antipyretic drugs | |
| CA2430091A1 (en) | An antibiotic/analgesic formulation and a method of making this formulation | |
| TW200533362A (en) | Use of meloxicam for the treatment of respiratory diseases in pig | |
| HRP20120639T1 (hr) | Fumaratna sol (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola | |
| RU2004115103A (ru) | Инъецируемые композиции для контролируемоей доставки фармакологически активного соединения | |
| JP2010106043A (ja) | テトラサイクリンの経口バイオアベイラビリティーを増加する方法 | |
| KR102700588B1 (ko) | 액체 드레싱 조성물 및 이의 수의학적 용도 | |
| JP2010090168A5 (enExample) | ||
| JP2008540394A5 (enExample) | ||
| SI2659881T1 (en) | Formulation of the delayed release medicinal product | |
| JP2013515002A5 (enExample) | ||
| JP2013501051A (ja) | ナノ粒子の溶液およびナノ粒子の懸濁物の両者を有する局所用薬学的調製物ならびに該調製物をもって急性疼痛および慢性疼痛を処置する方法 | |
| CN108025078A (zh) | 用于nsaid的固体溶液组合物 | |
| CN1625411A (zh) | Nsaid与pde－4抑制剂的并用药物 | |
| JP2002526407A5 (enExample) | ||
| EP2293777A1 (en) | Pharmaceutical transdermal compositions and method for treating inflammation in cattle | |
| JP2010513500A (ja) | ウシ類と他の動物における炎症を処置するための薬学的組成物および方法 | |
| JP2014530842A5 (enExample) | ||
| JP2015510928A5 (enExample) | ||
| JP2006523723A5 (enExample) | ||
| CA2522009A1 (en) | Methods for the controlled delivery of pharmacologically active compounds | |
| JP2007503433A5 (enExample) | ||
| JP2023533041A5 (enExample) | ||
| WO2005025488A3 (en) | Methods for the controlled delivery of pharmacologically active compounds |